These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14437278)

  • 1. [Treatment of various liver diseases with a new choleretic].
    REMELLI L; FRASCARIA F
    Gazz Med Ital; 1960 Feb; 119():70-4. PubMed ID: 14437278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apropos of the therapy of hepatovesical disorders with special reference to the cholagogic and choleretic effects of chlorobicarbonated thermal springs].
    LA BARRE J
    J Belge Med Phys Rhumatol; 1959; 14():140-50. PubMed ID: 14413104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cholerosis, choleretics, and liver and bile duct diseases].
    DEMEULENAERE L; CANDAELE N
    Belg Tijdschr Geneesk; 1959 Dec; 15():1273-83. PubMed ID: 13815813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic duodenal sounding with cholagogues and choleretics].
    REMELLI L; FRASCARIA F
    Gazz Med Ital; 1960 Feb; 119():67-70. PubMed ID: 13854493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and experimental research with Felviten (anetholtrithion)].
    ROETTER W
    Med Welt; 1961 Jun; 25():1353-5. PubMed ID: 13742717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences on the therapeutic activity of 1,4-dicaffeylquinic acid combined with liver-protective agents].
    PICCINELLI O
    Gazz Med Ital; 1959 Nov; 118():477-81. PubMed ID: 14432711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-radiological research with a new synthetic choleretic: 2-(1-hydroxy-4-phenyl-cyclohexyl)-butyric acid (M.G. 4833)].
    ANNONI G; LONGARETTI A; MANTERO E
    Minerva Med; 1960 Jan; 51():195-206. PubMed ID: 13793757
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
    VANCINI B
    Minerva Med; 1962 May; 53():1478-86. PubMed ID: 13924674
    [No Abstract]   [Full Text] [Related]  

  • 9. [On a combination of a synthetic choleretic and a "mixed" spasmolytic with vitamins B-I and PP, in the therapy of some hepatobiliary diseases. Clinical study].
    ABBONA C; GATTO PL
    Minerva Med; 1962 May; 53():1486-91. PubMed ID: 13858818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phytotherapy of liver and biliary diseases].
    SVOBODA DH
    Medizinische; 1959 Sep; 38():1772-4. PubMed ID: 13835972
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic cholagenesis by plants in liver diseases].
    GONZALEZ-GALVAN JM
    Clin Lab (Zaragoza); 1960 Jun; 69():430-5. PubMed ID: 13706959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with oxaphenamide of diseases of the bile ducts and liver].
    KARAPETIAN GN; VECHER AM
    Laboratorio; 1961 Jun; 39():103-5. PubMed ID: 13751419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effects of 1,4-dicaffeylquinic acid (cinarine) after oral, rectal, intravenous and intraduodenal administration].
    CIMA G; BONORA R
    Minerva Med; 1959 Jul; 50():2288-91. PubMed ID: 13810324
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic effects of 1-4-dicaffeil quinic acid (cynarine) administered by oral, rectal, intravenous and intraduodenal way.
    CIMA G; BONORA R
    Panminerva Med; 1960 Oct; 2():493-4. PubMed ID: 13693659
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of diseases of the bile ducts with a new choleretic (cholipin)].
    KLEINSCHMIDT W
    Med Monatsschr; 1961 Jun; 15():390-2. PubMed ID: 13756728
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
    Barbi G
    Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with cholipin, a new choleretic].
    BAMBERG H
    Ther Ggw; 1961 Nov; 100():564-7. PubMed ID: 13864547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present status of cholagogue and choleretic medication in biliary disorders].
    DEBRAY C; HARDOUIN JP
    Rev Prat; 1962 Feb; 12():596-9. PubMed ID: 13884680
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical evaluation of a choleretic with special emphasis on its effect on blood cholesterol.
    SCHWARTZ IR
    Am J Gastroenterol; 1962 Apr; 37():442-51. PubMed ID: 13909700
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trials with choleretic and hypocholesterolemic substances].
    MARTEL F
    Laval Med; 1962 Apr; 33():248-51. PubMed ID: 14470278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.